153 related articles for article (PubMed ID: 24371776)
1. Regression of a case of Multiple Myeloma with antiviral treatment in a patient with chronic HCV infection.
Panfilio S; D'Urso P; Annechini G; D'Elia GM; De Angelis F; Stefanizzi C; Pulsoni A
Leuk Res Rep; 2013; 2(1):39-40. PubMed ID: 24371776
[TBL] [Abstract][Full Text] [Related]
2. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience.
Vallisa D; Bernuzzi P; Arcaini L; Sacchi S; Callea V; Marasca R; Lazzaro A; Trabacchi E; Anselmi E; Arcari AL; Moroni C; Bertè R; Lazzarino M; Cavanna L
J Clin Oncol; 2005 Jan; 23(3):468-73. PubMed ID: 15659492
[TBL] [Abstract][Full Text] [Related]
3. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection.
Hermine O; Lefrère F; Bronowicki JP; Mariette X; Jondeau K; Eclache-Saudreau V; Delmas B; Valensi F; Cacoub P; Brechot C; Varet B; Troussard X
N Engl J Med; 2002 Jul; 347(2):89-94. PubMed ID: 12110736
[TBL] [Abstract][Full Text] [Related]
4. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.
Mihăilă RG
World J Gastroenterol; 2016 Jul; 22(27):6214-23. PubMed ID: 27468211
[TBL] [Abstract][Full Text] [Related]
6. Re-treatment of patients with hepatitis C who failed to respond (nonresponders) to previous treatment.
Sharvadze LG; Gogichaishvili ShSh; Sakandelidze TsG; Zhamutashvili MT; Chkhartishvili NI
Georgian Med News; 2009 Jan; (166):61-4. PubMed ID: 19202222
[TBL] [Abstract][Full Text] [Related]
7. Recurrence of HCV infection in a sustained responder after chemotherapy for non-Hodgkin's lymphoma: successful retreatment.
Thomopoulos K; Giannakoulas NC; Tsamandas AC; Mimidis K; Fragopanagou E; Pallasopoulou M; Lampropoulou-Karatza Ch
Am J Med Sci; 2008 Jul; 336(1):73-6. PubMed ID: 18626242
[TBL] [Abstract][Full Text] [Related]
8. Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.
Hartwell D; Jones J; Baxter L; Shepherd J
Health Technol Assess; 2011 Apr; 15(17):i-xii, 1-210. PubMed ID: 21473834
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report.
Zylberberg H; Benhamou Y; Lagneaux JL; Landau A; Chaix ML; Fontaine H; Bochet M; Poynard T; Katlama C; Pialoux G; Bréchot C; Pol S
Gut; 2000 Nov; 47(5):694-7. PubMed ID: 11034587
[TBL] [Abstract][Full Text] [Related]
10. The sustained virologic response of nonresponder hepatitis C virus patients with retreatment.
Akhan SC; Gurel E; Sayan M
Indian J Pathol Microbiol; 2011; 54(1):81-4. PubMed ID: 21393883
[TBL] [Abstract][Full Text] [Related]
11. Development of diffuse large B-cell lymphoma after sofosbuvir-ledipasvir treatment for chronic hepatitis C: A case report and literature review.
Sakai H; Miwa T; Ikoma Y; Hanai T; Nakamura N; Imai K; Kitagawa J; Shirakami Y; Kanemura N; Suetsugu A; Takai K; Shiraki M; Shimizu M
Mol Clin Oncol; 2020 Sep; 13(3):1. PubMed ID: 32754315
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.
Kalafateli M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011644. PubMed ID: 28285495
[TBL] [Abstract][Full Text] [Related]
13. Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection.
Su TH; Liu CJ; Tseng TC; Chou SW; Liu CH; Yang HC; Wu SJ; Chen PJ; Chen DS; Chen CL; Kao JH
Aliment Pharmacol Ther; 2019 Feb; 49(3):331-339. PubMed ID: 30592071
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological interventions for acute hepatitis C infection.
Kalafateli M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011644. PubMed ID: 30521693
[TBL] [Abstract][Full Text] [Related]
15. Ombitasvir, paritaprevir, and ritonavir plus ribavirin in adults with hepatitis C virus genotype 4 infection and cirrhosis (AGATE-I): a multicentre, phase 3, randomised open-label trial.
Asselah T; Hézode C; Qaqish RB; ElKhashab M; Hassanein T; Papatheodoridis G; Feld JJ; Moreno C; Zeuzem S; Ferenci P; Yu Y; Redman R; Pilot-Matias T; Mobashery N
Lancet Gastroenterol Hepatol; 2016 Sep; 1(1):25-35. PubMed ID: 28404108
[TBL] [Abstract][Full Text] [Related]
16. High dose daily interferon-alpha induction and secondary adjunction of ribavirin in treatment-naive patients with chronic hepatitis C. A multicentric, randomised, controlled trial.
Wartelle-Bladou C; Arpurt JP; Renou C; Pariente A; Pillon D; Nalet B; Picon M; Glibert A; Chousterman M; Grasset D; Morin T; Bernard P; Fischer D; Ramdani M; Lagier E; Rotily M;
Gastroenterol Clin Biol; 2006 Apr; 30(4):525-32. PubMed ID: 16733374
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus reactivation after successful treatment of hepatitis C virus with sofosbuvir and ribavirin: A case report and literature review.
Miyasaka A; Yoshida Y; Suzuki A; Masuda T; Okamoto H; Takikawa Y
Medicine (Baltimore); 2020 Oct; 99(41):e22650. PubMed ID: 33031326
[TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
19. Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma.
La Mura V; De Renzo A; Perna F; D'Agostino D; Masarone M; Romano M; Bruno S; Torella R; Persico M
J Hepatol; 2008 Oct; 49(4):557-63. PubMed ID: 18678434
[TBL] [Abstract][Full Text] [Related]
20. Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses.
Guptan RC; Thakur V; Raina V; Sarin SK
J Gastroenterol Hepatol; 1999 Sep; 14(9):893-8. PubMed ID: 10535471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
